Mean proportion of lifetime on transfusion therapy* for patients enrolled in the EPIC study included in these analyses.
*Determined by the number of years the subject had already received transfusion therapy divided by age at screening; regular or intermittent transfusions were not differentiated in the protocol.
Data from Taiwan were excluded because of inadequate data recording as a result of patients being referred to investigator sites for enrolment in the study.